OK, so perhaps you didn't have a chance to schmooze with Kevin Hickey, CEO of Internet real-estate broker
, after his recent speech at a venture capitalist conference. And you didn't get a crash course in data storage from high-ranking officials at
, like I did at yet another rubber-chicken luncheon of financial analysts.
So is there some other way for the average investor to get the inside scoop on key technologies before they become hot buzzwords among investing pros?
Thanks to the Internet, broadcast and cable TV, almost anyone today can become a financier extraordinaire. Today's investors have unprecedented access to the ever-toiling throngs of high-tech entrepreneurs through both free, and nearly-free media.
The key is knowing where to look.
Viewers of the "Inventing the Future" special a few seasons ago on the
show "Scientific American Frontiers" caught an early glance of wearable computers being designed at the
MIT Media Laboratory
. Following that thread might have led you to Fairfax, Va.-based
, a stock that has soared in recent months to 15 from less than 2.
Readers of the
New England Journal of Medicine
foresaw the tremendous potential of
lifesaving automatic external defibrillators, which may one day become as common as fire extinguishers. (Once
-traded, HeartStream is now part of
profiled Princeton, N.J.-based start-up
efforts to dramatically increase the pace of genotyping single nucleotide polymorphisms (SNPs) through the use of its proprietary microfluidic-array chips. Such "snips-on-chips" technologies are widely viewed as the key to realizing the potential of the Human Genome Project. Only last month, Orchid completed the largest ever self-managed private placement by a private company in the biotech field, raising a staggering $72 million. Watch for a possible IPO.
fleet of orbiting space shuttles are exotic hydrogen fuel cells. Canada's
Ballard Power Systems
is taking huge strides toward bringing such clean propulsion systems to the family car (perhaps as early as 2003) by perfecting an economical proton-exchange membrane (or PEM), the hydrogen fuel cell's essential component.
First developed in 1839 by Sir William Grove, and long considered impractical and prohibitively expensive, Geoff Ballard's tortuous and storied drive to get funding, reduce unit costs and increase wattage is the stuff of heroic perseverance. His story was the subject of a book,
Powering the Future: The Ballard Fuel Cell and the Race to Change the World
, by Tom Koppel (John Wiley & Sons). As if to confirm that PEM fuel cells are finally coming,
of Latham, N.Y., which went public last October, has electrified investors since.
So where else should investors keep an inquisitive eye, besides, of course,
? Cast your gaze toward
The Discovery Channel
regular "Technology on the Cutting Edge" features, NASA's (
www.nasa.gov) Technology Transfer Program,
Investors Business Daily's
"New America" page, Ziff-Davis'
VCs & Startups column, as well as
magazines. Likewise, check out
Materials Research Science and Engineering Centers
Sandia National Labs'
www.sandia.gov ) work on nanotechnology, buckyballs, nanotubes and micromachinery. These brilliant devices (still without apparent use) remind you of the birth of lasers, long before they became indispensable. And who hasn't dreamed of participating in the granddaddy of all hi-tech sleuthing activities: wandering the aisles of the annual
Comdex computer trade show in search of a newly crowded booth?
But finding a great emerging technology is only the first step; getting in and riding it to hefty profits is another. Part 2 of this report,
Case Study: Cree Investors See the Light, tracks an early investment in
, a pioneer in the commercial use of silicon carbide semiconductor wafers and devices.
James Brookes-Avey is chief investment officer of Scottsdale, Ariz.-based
MomentumInvesting.com. At the time of publication his firm had no position in Cree, and was long Ballard Power Systems, although positions can change at anytime. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Brookes-Avey's writings provide insight into the dynamics of money management and are not a solicitation for transactions. While he cannot provide investment advice or recommendations, he invites your feedback at